Conway added as General Election candidate in Clare
4th September 2018 - Senator Martin Conway
Fine Gael Senator Martin Conway has been added as a party candidate in the Clare constituency for the next General Election.
The Fine Gael Executive Council met this evening (Tuesday) and agreed on the addition of Senator Conway in his native county.
Senator Conway will be running alongside his party colleagues Minister Pat Breen and Deputy Joe Carey.
The well-respected Senator, who is visually impaired, is based in Ennistymon in Clare and is currently the Seanad Government Spokesperson on Justice and Equality.
Senator Conway said: “I am delighted this evening to be added to the Fine Gael ticket in Clare.
“Since I was first elected to Clare County Council in 2004, and subsequently the Seanad in 2011, it has always been a privilege to represent and serve the people of Clare.
“It would be an honour to be elected as a TD and to continue my current work, which focuses on justice and equality, in the Dáil.
“As a person with a disability and facing the challenges that goes with that, I relish the opportunity to be an advocate for the disability community on a more prominent national level. Fine Gael is an inclusive party and represents all strands of society and I look forward to the challenges that lie ahead,” Senator Conway said.
Senator Martin Conway
ClareMartin Conway is a member of the 26th Seanad and previously served in the 24th Seanad on the Administrative Panel,…
Related news
Ratification of optional protocol is a key step for equality – Conway
The decision to accede to the Optional Protocol to UN Convention on the Rights of Persons with Disabilities is a…
8th October 2024Conway pays tribute to Joe Carey
Clare Fine Gael Senator Martin Conway has paid tribute to his friend and political colleague Joe Carey who has announced…
26th August 2024Hugely successful Chronic Disease Management Programme is leading to better patient outcomes – Conway
The Chronic Disease Management Programme has been a huge success story and has led to better outcomes for some patients…
6th May 2024